enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	3.62	4.56	54.73	9.33	2.12	2.74	0.08	0.06
Short-Term Investments	42.79	34.49	0	0	0	0	0	0
Cash & Cash Equivalents	46.41	39.04	54.73	9.33	2.12	2.74	0.08	0.06
Cash Growth	18.87%	-28.66%	486.29%	340.87%	-22.74%	3427.76%	37.47%	-
Receivables	0	0	0	0	0	0.03	0.04	0.02
Inventory	0	0	0	0	0	0	0	0.09
Other Current Assets	0.51	0.39	0.31	0.23	-0.69	0.06	0.06	0.22
Total Current Assets	46.92	39.44	55.04	9.57	1.42	2.84	0.17	0.39
Property, Plant & Equipment	1.68	2.19	2.61	0.94	1.17	0.03	0.02	0.03
Goodwill and Intangibles	0	0	0	0	0	0.67	1.11	1.23
Other Long-Term Assets	0.03	0.03	0.05	0.03	0.84	0.03	0.91	0.13
Total Long-Term Assets	1.71	2.23	2.66	0.97	2.01	0.72	2.04	1.39
Total Assets	48.64	41.66	57.7	10.54	3.43	3.56	2.21	1.78
Accounts Payable	1.03	1.22	0.56	1.39	1.22	1.08	1.45	0.54
Deferred Revenue	0	0	0	0	0.03	0.03	0.1	0
Current Debt	0.34	0.31	0.29	0.63	0.29	0	2.62	0.63
Other Current Liabilities	0	0	0.73	1.17	0.33	0.41	4	0.89
Total Current Liabilities	1.37	1.53	1.58	3.19	1.88	1.52	8.17	2.07
Long-Term Debt	1.06	1.4	1.72	0.25	0.57	0	0	0
Total Long-Term Liabilities	1.06	1.4	1.72	0.25	0.57	0	0	0
Total Liabilities	2.44	2.93	3.3	3.44	2.44	1.52	8.17	2.07
Total Debt	1.4	1.72	2.01	0.88	0.86	0	2.62	0.63
Debt Growth	-18.30%	-14.46%	127.79%	2.80%	-	-	313.87%	-
Retained Earnings	-130.04	-106.52	-81.85	-65.32	-56.19	-48.56	-35.52	-27.73
Shareholders' Equity	46.2	38.73	54.4	7.1	0.99	2.04	-11.13	-4.22
Net Cash / Debt	45.01	37.33	52.72	8.45	1.26	2.74	-2.54	-0.58
Net Cash / Debt Growth	20.58%	-29.20%	523.64%	570.60%	-54.00%	-	-	-
Net Cash Per Share	3.66	3.32	6.07	6.55	2.00	7.32	-10.37	-2.38
Working Capital	45.55	37.91	53.46	6.38	-0.45	1.31	-8	-1.67
Book Value Per Share	3.76	3.45	6.27	5.50	1.57	5.44	-45.42	-17.46

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).